Arkansas takes part in settlement with drug maker

 
No Author Published: November 19, 2012    Comment on this article Leave a comment

LITTLE ROCK, Ark. (AP) — Arkansas is to receive $1.6 million as part of a 38-state settlement with drug maker GlaxoSmithKline LLC over the way it promoted the use of the diabetes drug Avandia.


Advertisement

Arkansas Attorney General Dustin McDaniel on Monday announced the state took part in a $90 million settlement with the states.

The company was accused of misrepresenting the risks of heart attack and stroke associated with Avandia.

The settlement requires GlaxoSmithKline to not make false, misleading or deceptive claims about any diabetes drugs.





If you prefer your thoughts to appear in The Oklahoman's Opinion section, we encourage you to submit a letter to the editor.


New Rule in WASHINGTON:
(MAY 2013): If You Pay For Car Insurance You Must Read This Immediately
www.ConsumerFinanceDaily.com
Diabetes Cure?
(Video) Man uncovers scientific research that destroys his diabetes.
DisarmDiabetes.com

News Photo Galleriesview all